Katie Wharry
About Katie Wharry
Katie Wharry serves as the Associate Vice President of Content Development at PRECISIONscientia, where she specializes in medical communications for autoimmune, metabolic, and rare diseases. With a strong background in research and healthcare education, she has held various roles in prominent institutions, including the University of Pennsylvania and ETHOS Health Communications.
Work at PRECISIONscientia
Katie Wharry has been serving as the Associate Vice President of Content Development at PRECISIONscientia since 2020. In this role, she focuses on developing content strategies that cater to both healthcare professionals and patients. Her work emphasizes medical communications, particularly in the therapeutic areas of autoimmune, metabolic, and rare diseases. Her position involves overseeing content development initiatives that align with the company's mission to enhance healthcare communication.
Education and Expertise
Katie Wharry holds a PhD in Cell & Molecular Biology from the University of Pennsylvania School of Medicine, where she studied from 2003 to 2009. She also earned a Bachelor of Science degree in Biochemistry & Molecular Biology from Penn State University, completing her studies there from 1999 to 2003. Her educational background provides a strong foundation for her expertise in medical communications, particularly in developing content for healthcare education.
Background in Medical Communications
Katie Wharry has extensive experience in the medical communications field. Prior to her current role, she worked as a Senior Scientific Director at ETHOS Health Communications from 2010 to 2020. Her responsibilities included business planning and strategy, contributing to her comprehensive understanding of the healthcare industry. Additionally, her previous roles in research at institutions such as the University of Pennsylvania and Cephalon have equipped her with a solid foundation in scientific communication.
Previous Research Experience
Katie Wharry has a diverse background in research, having worked in various capacities before her focus on medical communications. She was involved in Tumor Immunology Research at the University of Pennsylvania from 2003 to 2009. Earlier, she contributed to Chemistry & Oncology Research at Cephalon from 2001 to 2003, and she also conducted microbiology research at Penn State University from 2002 to 2003. Her research experience includes a role at the Stroud Water Research Center, where she focused on Stream Chemistry & Biology in 2000.